Febrikast AM 75mg/5mg/10mg Tablet SR
Marketer
Human Biolife India Pvt Ltd
Salt Composition
Ambroxol (75mg) + Levocetirizine (5mg) + Montelukast (10mg)
Overview Febrikast AM 75mg/5mg/10mg Tablet SR
RespirAid AM 75mg/5mg/10mg Extended-Release Tablets combine medications to manage respiratory illnesses involving thick mucus. This treatment offers relief from productive coughs linked to conditions such as asthma, bronchitis, and the common cold. The prescribed dose and duration of RespirAid AM 75mg/5mg/10mg Extended-Release Tablets should be followed precisely, with or without food. Treatment should continue as directed; premature discontinuation may lead to symptom recurrence and condition worsening. Inform your doctor of all other medications, as interactions are possible. Common, typically temporary, side effects include nausea, indigestion, dry mouth, flu-like symptoms, tiredness, and headache. Report any concerning side effects immediately. Drowsiness and dizziness are potential effects; avoid driving or mentally demanding tasks until the medication's impact is known. Alcohol consumption should be avoided due to increased drowsiness risk. Prior to use, disclose any kidney or liver conditions, and inform your doctor of pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Febrikast AM 75mg/5mg/10mg Tablet SR
No text provided to rephrase.
Uses of Febrikast AM 75mg/5mg/10mg Tablet SR
Managing respiratory conditions characterized by thick mucus.
Major Benefits of Febrikast AM 75mg/5mg/10mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length of this medication. Ingest the Febrikast AM 75mg/5mg/10mg SR tablet whole; avoid chewing, crushing, or breaking it. While this medication may be administered with or without food, consistent timing is recommended for optimal results.
Common Side effects of Febrikast AM 75mg/5mg/10mg Tablet SR:
- Nausea
- Upset stomach
- Dryness in mouth
- Headache
- Fatigue
- Allergic reaction
- Sleepiness
- Flu-like symptoms
How to use Febrikast AM 75mg/5mg/10mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Febrikast AM 75mg/5mg/10mg SR Tablets. Ingest the tablet whole; do not crush, chew, or divide it. While this medication can be taken with or without food, consistent daily timing is recommended for optimal results.
How Febrikast AM 75mg/5mg/10mg Tablet SR works:
Each Febrikast AM 75mg/5mg/10mg sustained-release tablet unites ambroxol, levocetirizine, and montelukast to address respiratory symptoms. Ambroxol, a mucolytic agent, facilitates mucus expectoration by reducing its viscosity. Levocetirizine, an antihistamine, targets allergic rhinitis manifestations such as nasal discharge, lacrimation, and sneezing. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thus diminishing airway and nasal inflammation and improving symptom control.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining alcohol and Febrikast AM 75mg/5mg/10mg SR tablets. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The extended-release Febrikast AM 75mg/5mg/10mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release combination tablet Febrikast AM (75mg/5mg/10mg) is likely unsuitable for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Febrikast AM 75mg/5mg/10mg SR tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
For individuals with impaired kidney function, the use of Febrikast AM 75mg/5mg/10mg SR tablets requires careful monitoring. Dosage modifications of Febrikast AM 75mg/5mg/10mg SR tablets may be necessary. Physician consultation is advised. Febrikast AM 75mg/5mg/10mg SR tablets are contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should exercise caution when taking Febrikast AM 75mg/5mg/10mg Tablet SR. Dosage modification of Febrikast AM 75mg/5mg/10mg Tablet SR might be necessary. Physician consultation is advised.
What if you forget to take Febrikast AM 75mg/5mg/10mg Tablet SR :
Should you forget a dose of Febrikast AM 75mg/5mg/10mg sustained-release tablet, take it immediately if remembered. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Febrikast AM 75mg/5mg/10mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Breathing |
3,018 People bought this recently